GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Total Liabilities

Hwail Pharm Co (XKRX:061250) Total Liabilities : ₩11,114 Mil (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Hwail Pharm Co Total Liabilities?

Hwail Pharm Co's Total Liabilities for the quarter that ended in Mar. 2024 was ₩11,114 Mil.

Hwail Pharm Co's quarterly Total Liabilities increased from Sep. 2023 (₩9,518.42 Mil) to Dec. 2023 (₩11,547.84 Mil) but then declined from Dec. 2023 (₩11,547.84 Mil) to Mar. 2024 (₩11,114.41 Mil).

Hwail Pharm Co's annual Total Liabilities declined from Dec. 2021 (₩12,488.94 Mil) to Dec. 2022 (₩10,023.75 Mil) but then increased from Dec. 2022 (₩10,023.75 Mil) to Dec. 2023 (₩11,547.84 Mil).


Hwail Pharm Co Total Liabilities Historical Data

The historical data trend for Hwail Pharm Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hwail Pharm Co Total Liabilities Chart

Hwail Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19,970.00 12,816.01 12,488.94 10,023.75 11,547.84

Hwail Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,754.10 11,806.95 9,518.42 11,547.84 11,114.41

Hwail Pharm Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hwail Pharm Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=11025.895+(206.823+315.123
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=11,548

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=186001.476-174453.635
=11,548

Hwail Pharm Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=10621.471+(176.202+316.736
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=11,114

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=186723.697-175609.288
=11,114

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hwail Pharm Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hwail Pharm Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Hwail Pharm Co (XKRX:061250) Business Description

Traded in Other Exchanges
N/A
Address
904-7, Sangsin-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-746
Hwail Pharm Co Ltd is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory, and others.

Hwail Pharm Co (XKRX:061250) Headlines

No Headlines